PHF8 Human siRNA Oligo Duplex (Locus ID 23133)
CAT#: SR308029
PHF8 (Human) - 3 unique 27mer siRNA duplexes - 2 nmol each
Need single siRNA in bulk? 
                            Get a free quote
                        
CNY 4090.00
货期*
                        4周
                    规格
                        | Cited in 1 publication. | 
Product images
                    
                
                         推荐一起购买 (3)
                    
                    
                Specifications
| Product Data | |
| Purity | HPLC purified | 
| Quality Control | Tested by ESI-MS | 
| Sequences | Available with shipment | 
| Stability | One year from date of shipment when stored at -20°C. | 
| # of transfections | Approximately 330 transfections/2nmol in 24-well plate under optimized conditions (final conc. 10 nM). | 
| Note | Single siRNA duplex (10nmol) can be ordered. | 
| Reference Data | |
| RefSeq | NM_001184896, NM_001184897, NM_001184898, NM_015107 | 
| Synonyms | JHDM1F; KDM7B; MRXSSD; ZNF422 | 
| Components | PHF8 (Human) - 3 unique 27mer siRNA duplexes - 2 nmol each (Locus ID 23133)Included - SR30004, Trilencer-27 Universal Scrambled Negative Control siRNA Duplex - 2 nmolIncluded - SR30005, RNAse free siRNA Duplex Resuspension Buffer - 2 ml | 
| Summary | The protein encoded by this gene is a histone lysine demethylase that preferentially acts on histones in the monomethyl or dimethyl states. The encoded protein requires Fe(2+) ion, 2-oxoglutarate, and oxygen for its catalytic activity. The protein has an N-terminal PHD finger and a central Jumonji C domain. This gene is thought to function as a transcription activator. Defects in this gene are a cause of syndromic X-linked Siderius type intellectual disability (MRXSSD) and over-expression of this gene is associated with several forms of cancer. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2017] | 
| Performance Guranteed | OriGene guarantees that at least two of the three Dicer-Substrate duplexes in the kit will provide at least 70% or more knockdown of the target mRNA when used at 10 nM concentration by quantitative RT-PCR when the TYE-563 fluorescent transfection control duplex (cat# SR30002) indicates that >90% of the cells have been transfected and the HPRT positive control (cat# SR30003) provides 90% knockdown efficiency. For non-conforming siRNA, requests for replacement product must be made within ninety (90) days from the date of delivery of the siRNA kit. To arrange for a free replacement with newly designed duplexes, please contact Technical Services at techsupport@origene.com. Please provide your data indicating the transfection efficiency and measurement of gene expression knockdown compared to the scrambled siRNA control (quantitative RT-PCR data required).  | 
        
Citations (1)
| The use of this RNAi has been cited in the following citations: | 
|---|
| 
                                                c-MYC drives histone demethylase PHF8 during neuroendocrine differentiation and in castration-resistant prostate cancer
                                                ,Maina, PK;Shao, P;Liu, Q;Fazli, L;Tyler, S;Nasir, M;Dong, X;Qi, HH;,
                                                Oncotarget
                                                ,PubMed ID 27689328
                                                [PHF8]
                                                 | 
                                        
Documents
| Product Manuals | 
| FAQs | 
| SDS | 
                         Customer
                                Reviews 
                    
                    
                                Loading...
                            
                        